Various green fluorescent protein (GFP)-based tools now allow for the observation of changes in the organisation of actin, myosin and cell adhesions in the lead-up to and during morphogenetic events [1] [2] [3] . Genetic studies have also revealed a great deal about the upstream events that are required for morphogenesis, such as local signalling pathways or the transcription of specific morphogenetic regulators. However, the biggest gaps in our knowledge concern the links between these upstream events and the downstream changes in the organisation of actomyosin and cell-cell adhesions.
Bridging these gaps will be crucial to gaining a complete understanding of how tissues and organs are shaped during development. Recent work using Drosophila embryogenesis as a model system has made sizable steps towards doing just that [4] [5] [6] [7] .
One well studied example of morphogenesis is gastrulation, the process whereby the different cell layers of the embryo are laid down. In the Drosophila embryo, gastrulation begins with the invagination of a group of cells on the ventral surface of the embryo, forming the ventral furrow (reviewed in [8] ). The cells of the ventral furrow are internalized and will later undergo an epithelial to mesenchymal transition to form the mesoderm precursors of the embryo. Ventral furrow formation is driven by the apical constriction of the ventral cells, which causes them to change from cuboidal to wedge-shaped -a transition that forces them inside the embryo ( Figure 1A) . The apical constriction of the ventral cells is brought about by the local accumulation of actin and myosin II at the apical end of the cells [1] .
The upstream control of Drosophila gastrulation has been well characterised by genetic analyses. Two transcription factors, Twist and Snail, define the ventral domain and induce the expression of specific target genes [9] . One such target gene is folded gastrulation (fog), which encodes a secreted ligand [10] . The Fog signal operates through Concertina (Cta), a heterotrimeric G-protein subunit [11] , to activate RhoGEF2 [12, 13] . RhoGEF2 is an activator of the small GTPase Rho1, a potent regulator of the actin cytoskeleton and myosin. It thus provides a link between the upstream signalling events and the downstream changes in actomyosin organisation. Indeed, in RhoGEF2 mutants, myosin II no longer accumulates apically in the ventral cells and these cells no longer constrict and, as a consequence, the ventral furrow does not form [7, 12] . Superficially, this seems to be a reasonably complete explanation of how the ventral furrow is formed, but there are some problems with this description. Firstly, genetic studies show that, while RhoGEF2 null mutants display a strong gastrulation defect, the phenotypes of fog and cta mutants are much weaker, as some cell constriction occurs and the ventral cells are still internalized [11, 12, 14] . These differences suggest that RhoGEF2 may be involved in a second pathway, independent of Fog and Cta. Secondly, while we can explain why it is only the ventral cells that constrict -only these cells receive the Fog signal -we can't explain why constriction, and the accumulation of myosin II and actin that it requires, is limited to just the apical side of these cells. The recent discovery by Kö lsch et al. [5] of T48 -a transmembrane protein that can recruit RhoGEF2 and adherens junctions to the apical surface of ventral cells and acts in parallel to Fog/Cta -may go some way to answering these questions. T48 was originally discovered in a genetic screen for genes that control gastrulation [15] . The T48 gene encodes a predicted protein with a signal peptide and a transmembrane domain. In keeping with a possible role in gastrulation, T48 is expressed in the mesoderm of the fly embryo under the control of Twist [5] . Furthermore, T48 localises to the apical membrane of the blastoderm, the site to which myosin II and RhoGEF2 relocalise as ventral furrow formation begins. The carboxyl terminus of T48 contains a consensus sequence for interaction with PDZ domains and Kö lsch et al. [5] use a protein interaction algorithm to predict PDZ domain containing proteins that are most likely to interact with T48. One interactor identified this way is RhoGEF2 and its interaction with T48 is confirmed by the authors using in vitro binding assays. Crucially, Kö lsch et al. [5] find that GFP-tagged RhoGEF2 in fly S2 cells relocalises from the cytoplasm to the plasma membrane after the addition of T48, indicating that T48 can mediate the recruitment of RhoGEF2 to the plasma membrane.
What about the function of T48 in the embryo? Kö lsch et al. [5] demonstrate a requirement for T48 in the early stages of gastrulation and, specifically, for the relocalisation of RhoGEF2 to the apical membrane of ventral cells. In wild type embryos before gastrulation, RhoGEF2 is found along the basal surface of the blastoderm epithelium ( Figure 1B) . Just as gastrulation is about to begin, RhoGEF2 disappears basally and, shortly after, high levels of RhoGEF2 accumulate at the apical side of the ventral cells, which begin to flatten apically. This pattern of relocalisation from the basal to apical edge of the ventral cell mirrors that observed with adherens junctions and myosin II. In contrast to the wild type, T48 loss-of-function embryos do not show such a dramatic concentration of RhoGEF2 at the apical side of their ventral cells and, although these cells do begin to flatten, the ventral furrow does not invaginate properly. The phenotype of T48 mutants is similar to that caused by loss of Fog or Cta: ventral cells still change shape to some degree and furrow formation is not completely abolished -a weaker phenotype than seen in the RhoGEF2 null, which completely fails to form a furrow. This suggests that T48 and Fog/Cta signalling are both contributing to the apical recruitment of RhoGEF2 in ventral cells. This appears to be the case, as Kö lsch et al. [5] find that embryos lacking both T48 and Cta have a much stronger gastrulation phenotype, failing to accumulate RhoGEF2 apically and showing no ventral invagination ( Figure 1B) . These results indicate that T48 and Fog/Cta are acting in parallel pathways to localise RhoGEF2 to the apical end of ventral cells.
So, how can we fit this together to form a coherent picture of ventral furrow formation? Fox and Peifer [6] suggest a multi-pathway model, whereby the Fog/Cta pathway regulates apical myosin via RhoGEF2, whilst a second pathway -also operating through RhoGEF2 and assisted by the cytoskeletal regulators Abl and Ena -organises apical actin [6] . It seems likely that with T48 Kö lsch et al. [5] have uncovered the regulator of RhoGEF2 in this second pathway ( Figure 1C) . Intriguingly, in another invagination event -during formation of the spiracles, the respiratory organ of the fly larva -Simões et al. [4] showed that RhoGEF2 and RhoGEF64C are specifically localised to the apical edge of invaginating cells. It will be interesting to discover whether the T48 machinery employed for gastrulation is reused for this later step.
In conclusion, recent work in the Drosophila embryo has begun to identify solid links between upstream signalling pathways and downstream changes in the organization of the cytoskeleton during morphogenesis. A general mechanism is emerging, whereby the local control of the cytoskeleton is mediated via the targeted recruitment of cytoskeletal regulators, such as the RhoGEFs.
